Prognostic and Predictive Value of KRAS Mutation in NSCLC

被引：1
|
作者：
Yamamoto, Satomi [1 ]
Washington, Laurie [1 ]
Komiya, Takefumi [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Med Oncol, Fairway, KS 66205 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2016.04.035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E128 / +
页数：2
相关论文
共 50 条
  • [21] Age-dependent prognostic value of KRAS mutation in metastatic colorectal cancer
    Ozer, Muhammet
    Goksu, Suleyman Yasin
    Sanford, Nina Niu
    Ahn, Chul
    Beg, Muhammad Shaalan
    Kazmi, Syed Mohammad Ali
    FUTURE ONCOLOGY, 2021, 17 (35) : 4883 - 4893
  • [22] Meta-analysis on prognostic value of KRAS mutation in resected massforming cholangiocarcinoma
    Procopio, Fabio
    Branciforte, Bruno
    Nappo, Gennaro
    Di Tommaso, Luca
    Lleo, Ana
    Torzilli, Guido
    EJSO, 2022, 48 (07): : 1455 - 1463
  • [23] Prognostic and predictive effects of KRAS mutation subtype in completely resected non-small cell lung cancer (NSCLC): A LACE-bio study
    Shepherd, Frances A.
    Bourredjem, Abderrahmane
    Brambilla, Elisabeth
    Domerg, Caroline
    Douillard, Jean-Yves
    Filipits, Martin
    Graziano, Stephen L.
    Hainaut, Pierre
    Janne, Pasi Antero
    Le Chevalier, Thierry
    Le Teuff, Gwenael
    Pignon, Jean-Pierre
    Pirker, Robert
    Seymour, Lesley
    Soria, Jean-Charles
    Taron, Miquel
    Tsao, Ming Sound
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] KRAS mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
    Klikovits, Thomas
    Lohinai, Zoltan
    Moldvay, Judit
    Ostoros, Gyula
    Raso, Erzsebet
    Timar, Jozsef
    Fabian, Katalin
    Kovalszky, Ilona
    Kenessey, Istvan
    Aigner, Clemens
    Renyi-Vamos, Ferenc
    Klepetko, Walter
    Hoda, Mir Alireza
    Hegedus, Balazs
    Doeme, Balazs
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 770 - 770
  • [25] Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer A Review
    Wood, Kevin
    Hensing, Thomas
    Malik, Raeva
    Salgia, Ravi
    JAMA ONCOLOGY, 2016, 2 (06) : 805 - 812
  • [26] Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
    Diez-Alonso, Manuel
    Mendoza-Moreno, Fernando
    Gomez-Sanz, Remedios
    Matias-Garcia, Belen
    Ovejero-Merino, Enrique
    Molina, Raquel
    Soto-Schutte, Sonia
    San Juan, Alberto
    Gutierrez-Calvo, Alberto
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2021, 2021
  • [27] KRAS as predictive biomarker of response to checkpoint inhibitors in NSCLC
    Addeo, A.
    Torralvo, J.
    Dietrich, P-Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S114 - S115
  • [28] PROGNOSTIC AND PREDICTIVE VALUE OF KRAS AND BRAF MUTATIONS IN PATIENTS ENROLLED IN THE MRC FOCUS TRIAL
    Richman, S. D.
    Chambers, P.
    Elliott, F.
    Daly, C.
    Barrett, J.
    Taylor, G.
    Quirke, P.
    Seymour, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 166 - 166
  • [29] Age-dependent prognostic value of KRAS mutation in metastatic colon cancer.
    Ozer, Muhammet
    Goksu, Suleyman Yasin
    Sanford, Nina Niu
    Aguilera, Todd Anthony
    Kainthla, Radhika
    Jones, Amy Little
    Sanjeevaiah, Aravind
    Beg, Muhammad Shaalan
    Kazmi, Syed Mohammad Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer (NSCLC) patients.
    Fung, Andrea S.
    Karimi, Maryam
    Michiels, Stefan
    Seymour, Lesley
    Brambilla, Elisabeth
    Le Chevalier, Thierry
    Soria, Jean-Charles
    Kratzke, Robert Arthur
    Graziano, Stephen L.
    Devarakonda, Siddhartha
    Govindan, Ramaswamy
    Tsao, Ming-Sound
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345